Trimetrexate Glucuronate

三甲曲沙

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrimetrexate Glucuronate
Drug Alias Name三甲曲沙葡糖醛酸盐trimetrexato葡萄糖醛酸三甲曲沙trimetrexatum三甲曲沙葡萄糖醛酸 +[12
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsPneumonia
Global Approved IndicationsPneumonia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1993/12/17
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Oncology Inc
Active IndicationsN/A
Inactive IndicationsPneumonia

Other Information

ATC CodeP01AX07